Skip to main content
Top
Published in: Diabetologia 6/2009

01-06-2009 | Article

Ambulatory blood pressure measurements are related to albumin excretion and are predictive for risk of microalbuminuria in young people with type 1 diabetes

Authors: M. L. Marcovecchio, R. N. Dalton, C. P. Schwarze, A. T. Prevost, H. A. W. Neil, C. L. Acerini, T. Barrett, J. D. Cooper, J. Edge, J. Shield, B. Widmer, J. A. Todd, D. B. Dunger

Published in: Diabetologia | Issue 6/2009

Login to get access

Abstract

Aims/hypothesis

The relationship between BP and microalbuminuria in young people with type 1 diabetes is not completely clear. As microalbuminuria is preceded by a gradual rise in albumin excretion within the normal range, we hypothesised that ambulatory BP (ABP) may be closely related to albumin excretion and progression to microalbuminuria.

Methods

ABP monitoring (ABPM) was performed in 509 young people with type 1 diabetes (age median [range]: 15.7 [10.7–22.6] years) followed with annual assessments of three early morning urinary albumin:creatinine ratios (ACRs) and HbA1c. Systolic BP (SBP) and diastolic BP (DBP) and the nocturnal fall in BP were analysed in relation to ACR.

Results

All ABPM variables were significantly related to baseline log10 ACR (p < 0.001). After the ABPM evaluation, 287 patients were followed for a median of 2.2 (1.0–5.5) years. ABP at baseline was independently related to mean ACR during follow-up. Nineteen initially normoalbuminuric patients developed microalbuminuria after 2.0 (0.2–4.0) years and their baseline daytime DBP was higher than in normoalbuminuric patients (p < 0.001). After adjusting for baseline ACR and HbA1c, there was an 11% increased risk of microalbuminuria for each 1 mmHg increase in daytime DBP. Forty-eight per cent of patients were non-dippers for SBP and 60% for DBP; however, ACR was not different between dippers and non-dippers and there were no differences in the nocturnal fall in BP between normoalbuminuric and future microalbuminuric patients.

Conclusions/interpretation

In this cohort of young people with type 1 diabetes, ABP was significantly related to ACR, and daytime DBP was independently associated with progression to microalbuminuria. Increasing albumin excretion, even in the normal range, may be associated with parallel rises in BP.
Appendix
Available only for authorised users
Literature
1.
go back to reference Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T (2005) Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care 28:164–176PubMedCrossRef Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T (2005) Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care 28:164–176PubMedCrossRef
2.
go back to reference Rossing P, Hougaard P, Borch-Johnsen K, Parving HH (1996) Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study. BMJ 313:779–784PubMed Rossing P, Hougaard P, Borch-Johnsen K, Parving HH (1996) Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study. BMJ 313:779–784PubMed
3.
go back to reference Rudberg S, Stattin EL, Dahlquist G (1998) Familial and perinatal risk factors for micro- and macroalbuminuria in young IDDM patients. Diabetes 47:1121–1126PubMedCrossRef Rudberg S, Stattin EL, Dahlquist G (1998) Familial and perinatal risk factors for micro- and macroalbuminuria in young IDDM patients. Diabetes 47:1121–1126PubMedCrossRef
4.
go back to reference ACE Inhibitors in Diabetic Nephropathy Trialist Group (2001) Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? A meta-analysis of individual patient data. Ann Intern Med 134:370–379 ACE Inhibitors in Diabetic Nephropathy Trialist Group (2001) Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? A meta-analysis of individual patient data. Ann Intern Med 134:370–379
5.
go back to reference Moore WV, Donaldson DL, Chonko AM, Ideus P, Wiegmann TB (1992) Ambulatory blood pressure in type I diabetes mellitus. Comparison to presence of incipient nephropathy in adolescents and young adults. Diabetes 41:1035–1041PubMedCrossRef Moore WV, Donaldson DL, Chonko AM, Ideus P, Wiegmann TB (1992) Ambulatory blood pressure in type I diabetes mellitus. Comparison to presence of incipient nephropathy in adolescents and young adults. Diabetes 41:1035–1041PubMedCrossRef
6.
go back to reference Anon (1993) Risk factors for development of microalbuminuria in insulin dependent diabetic patients: a cohort study. Microalbuminuria Collaborative Study Group, United Kingdom. BMJ 306:1235–1239CrossRef Anon (1993) Risk factors for development of microalbuminuria in insulin dependent diabetic patients: a cohort study. Microalbuminuria Collaborative Study Group, United Kingdom. BMJ 306:1235–1239CrossRef
7.
go back to reference Schultz CJ, Neil HA, Dalton RN, Konopelska Bahu T, Dunger DB (2001) Blood pressure does not rise before the onset of microalbuminuria in children followed from diagnosis of type 1 diabetes. Oxford Regional Prospective Study Group. Diabetes Care 24:555–560PubMedCrossRef Schultz CJ, Neil HA, Dalton RN, Konopelska Bahu T, Dunger DB (2001) Blood pressure does not rise before the onset of microalbuminuria in children followed from diagnosis of type 1 diabetes. Oxford Regional Prospective Study Group. Diabetes Care 24:555–560PubMedCrossRef
8.
go back to reference Poulsen PL, Hansen KW, Mogensen CE (1994) Ambulatory blood pressure in the transition from normo- to microalbuminuria. A longitudinal study in IDDM patients. Diabetes 43:1248–1253PubMedCrossRef Poulsen PL, Hansen KW, Mogensen CE (1994) Ambulatory blood pressure in the transition from normo- to microalbuminuria. A longitudinal study in IDDM patients. Diabetes 43:1248–1253PubMedCrossRef
9.
go back to reference Mathiesen ER, Ronn B, Jensen T, Storm B, Deckert T (1990) Relationship between blood pressure and urinary albumin excretion in development of microalbuminuria. Diabetes 39:245–249PubMedCrossRef Mathiesen ER, Ronn B, Jensen T, Storm B, Deckert T (1990) Relationship between blood pressure and urinary albumin excretion in development of microalbuminuria. Diabetes 39:245–249PubMedCrossRef
10.
go back to reference Pickering TG, Shimbo D, Haas D (2006) Ambulatory blood-pressure monitoring. N Engl J Med 354:2368–2374PubMedCrossRef Pickering TG, Shimbo D, Haas D (2006) Ambulatory blood-pressure monitoring. N Engl J Med 354:2368–2374PubMedCrossRef
11.
go back to reference Lurbe E, Sorof JM, Daniels SR (2004) Clinical and research aspects of ambulatory blood pressure monitoring in children. J Pediatr 144:7–16PubMedCrossRef Lurbe E, Sorof JM, Daniels SR (2004) Clinical and research aspects of ambulatory blood pressure monitoring in children. J Pediatr 144:7–16PubMedCrossRef
12.
go back to reference Mancia G, Parati G (2000) Ambulatory blood pressure monitoring and organ damage. Hypertension 36:894–900PubMed Mancia G, Parati G (2000) Ambulatory blood pressure monitoring and organ damage. Hypertension 36:894–900PubMed
13.
go back to reference Hansen KW, Mau Pedersen M, Marshall SM, Christiansen JS, Mogensen CE (1992) Circadian variation of blood pressure in patients with diabetic nephropathy. Diabetologia 35:1074–1079PubMedCrossRef Hansen KW, Mau Pedersen M, Marshall SM, Christiansen JS, Mogensen CE (1992) Circadian variation of blood pressure in patients with diabetic nephropathy. Diabetologia 35:1074–1079PubMedCrossRef
14.
go back to reference Lurbe A, Redon J, Pascual JM, Tacons J, Alvarez V, Batlle DC (1993) Altered blood pressure during sleep in normotensive subjects with type I diabetes. Hypertension 21:227–235PubMed Lurbe A, Redon J, Pascual JM, Tacons J, Alvarez V, Batlle DC (1993) Altered blood pressure during sleep in normotensive subjects with type I diabetes. Hypertension 21:227–235PubMed
15.
go back to reference Lurbe E, Redon J, Kesani A et al (2002) Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N Engl J Med 347:797–805PubMedCrossRef Lurbe E, Redon J, Kesani A et al (2002) Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N Engl J Med 347:797–805PubMedCrossRef
16.
go back to reference Poulsen PL, Juhl B, Ebbehoj E, Klein F, Christiansen C, Mogensen CE (1997) Elevated ambulatory blood pressure in microalbuminuric IDDM patients is inversely associated with renal plasma flow. A compensatory mechanism? Diabetes Care 20:429–432PubMedCrossRef Poulsen PL, Juhl B, Ebbehoj E, Klein F, Christiansen C, Mogensen CE (1997) Elevated ambulatory blood pressure in microalbuminuric IDDM patients is inversely associated with renal plasma flow. A compensatory mechanism? Diabetes Care 20:429–432PubMedCrossRef
17.
go back to reference Hovind P, Tarnow L, Rossing P et al (2004) Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study. BMJ 328:1105PubMedCrossRef Hovind P, Tarnow L, Rossing P et al (2004) Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study. BMJ 328:1105PubMedCrossRef
18.
go back to reference Messent JW, Elliott TG, Hill RD, Jarrett RJ, Keen H, Viberti GC (1992) Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: a twenty-three year follow-up study. Kidney Int 41:836–839PubMedCrossRef Messent JW, Elliott TG, Hill RD, Jarrett RJ, Keen H, Viberti GC (1992) Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: a twenty-three year follow-up study. Kidney Int 41:836–839PubMedCrossRef
19.
go back to reference Klausen K, Borch-Johnsen K, Feldt-Rasmussen B et al (2004) Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation 110:32–35PubMedCrossRef Klausen K, Borch-Johnsen K, Feldt-Rasmussen B et al (2004) Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation 110:32–35PubMedCrossRef
20.
go back to reference Giorgino F, Laviola L, Cavallo Perin P, Solnica B, Fuller J, Chaturvedi N (2004) Factors associated with progression to macroalbuminuria in microalbuminuric Type 1 diabetic patients: the EURODIAB Prospective Complications Study. Diabetologia 47:1020–1028PubMedCrossRef Giorgino F, Laviola L, Cavallo Perin P, Solnica B, Fuller J, Chaturvedi N (2004) Factors associated with progression to macroalbuminuria in microalbuminuric Type 1 diabetic patients: the EURODIAB Prospective Complications Study. Diabetologia 47:1020–1028PubMedCrossRef
21.
go back to reference Dunger DB, Schwarze CP, Cooper JD et al (2007) Can we identify adolescents at high risk for nephropathy before the development of microalbuminuria? Diabet Med 24:131–136PubMedCrossRef Dunger DB, Schwarze CP, Cooper JD et al (2007) Can we identify adolescents at high risk for nephropathy before the development of microalbuminuria? Diabet Med 24:131–136PubMedCrossRef
23.
go back to reference O’Brien E, Coats A, Owens P et al (2000) Use and interpretation of ambulatory blood pressure monitoring: recommendations of the British hypertension society. BMJ 320:1128–1134PubMedCrossRef O’Brien E, Coats A, Owens P et al (2000) Use and interpretation of ambulatory blood pressure monitoring: recommendations of the British hypertension society. BMJ 320:1128–1134PubMedCrossRef
24.
go back to reference Dost A, Klinkert C, Kapellen T et al (2008) Arterial hypertension determined by ambulatory blood pressure profiles: contribution to microalbuminuria risk in a multicenter investigation in 2105 children and adolescents with diabetes mellitus type 1. Diabetes Care 31:720–725PubMedCrossRef Dost A, Klinkert C, Kapellen T et al (2008) Arterial hypertension determined by ambulatory blood pressure profiles: contribution to microalbuminuria risk in a multicenter investigation in 2105 children and adolescents with diabetes mellitus type 1. Diabetes Care 31:720–725PubMedCrossRef
25.
go back to reference Williams RM, Yuen K, White D et al (2006) Short-term suppression of elevated growth hormone concentrations following insulin-like growth factor 1 administration in young adults with type 1 diabetes does not alter glomerular filtration or albumin excretion rates. Clin Endocrinol (Oxf) 65:439–445CrossRef Williams RM, Yuen K, White D et al (2006) Short-term suppression of elevated growth hormone concentrations following insulin-like growth factor 1 administration in young adults with type 1 diabetes does not alter glomerular filtration or albumin excretion rates. Clin Endocrinol (Oxf) 65:439–445CrossRef
26.
go back to reference Cole TJ (1990) The LMS method for constructing normalized growth standards. Eur J Clin Nutr 44:45–60PubMed Cole TJ (1990) The LMS method for constructing normalized growth standards. Eur J Clin Nutr 44:45–60PubMed
27.
go back to reference Schultz CJ, Konopelska-Bahu T, Dalton RN et al (1999) Microalbuminuria prevalence varies with age, sex, and puberty in children with type 1 diabetes followed from diagnosis in a longitudinal study. Oxford Regional Prospective Study Group. Diabetes Care 22:495–502PubMedCrossRef Schultz CJ, Konopelska-Bahu T, Dalton RN et al (1999) Microalbuminuria prevalence varies with age, sex, and puberty in children with type 1 diabetes followed from diagnosis in a longitudinal study. Oxford Regional Prospective Study Group. Diabetes Care 22:495–502PubMedCrossRef
28.
go back to reference Wuhl E, Witte K, Soergel M, Mehls O, Schaefer F (2002) Distribution of 24-h ambulatory blood pressure in children: normalized reference values and role of body dimensions. J Hypertens 20:1995–2007PubMedCrossRef Wuhl E, Witte K, Soergel M, Mehls O, Schaefer F (2002) Distribution of 24-h ambulatory blood pressure in children: normalized reference values and role of body dimensions. J Hypertens 20:1995–2007PubMedCrossRef
29.
go back to reference Shankar RR, Eckert GJ, Saha C, Tu W, Pratt JH (2005) The change in blood pressure during pubertal growth. J Clin Endocrinol Metab 90:163–167PubMedCrossRef Shankar RR, Eckert GJ, Saha C, Tu W, Pratt JH (2005) The change in blood pressure during pubertal growth. J Clin Endocrinol Metab 90:163–167PubMedCrossRef
30.
go back to reference Torchinsky MY, Gomez R, Rao J, Vargas A, Mercante DE, Chalew SA (2004) Poor glycemic control is associated with increased diastolic blood pressure and heart rate in children with Type 1 diabetes. J Diabetes Complications 18:220–223PubMedCrossRef Torchinsky MY, Gomez R, Rao J, Vargas A, Mercante DE, Chalew SA (2004) Poor glycemic control is associated with increased diastolic blood pressure and heart rate in children with Type 1 diabetes. J Diabetes Complications 18:220–223PubMedCrossRef
31.
go back to reference Darcan S, Goksen D, Mir S et al (2006) Alterations of blood pressure in type 1 diabetic children and adolescents. Pediatr Nephrol 21:672–676PubMedCrossRef Darcan S, Goksen D, Mir S et al (2006) Alterations of blood pressure in type 1 diabetic children and adolescents. Pediatr Nephrol 21:672–676PubMedCrossRef
32.
go back to reference Palmas W, Moran A, Pickering T et al (2006) Ambulatory pulse pressure and progression of urinary albumin excretion in older patients with type 2 diabetes mellitus. Hypertension 48:301–308PubMedCrossRef Palmas W, Moran A, Pickering T et al (2006) Ambulatory pulse pressure and progression of urinary albumin excretion in older patients with type 2 diabetes mellitus. Hypertension 48:301–308PubMedCrossRef
33.
go back to reference Franklin SS, Larson MG, Khan SA et al (2001) Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study. Circulation 103:1245–1249PubMed Franklin SS, Larson MG, Khan SA et al (2001) Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study. Circulation 103:1245–1249PubMed
34.
go back to reference Knudsen ST Laugesen E, Hansen KW, Bek T, Mogensen CE, Poulsen PL (2009) Ambulatory pulse pressure, decreased nocturnal blood pressure reduction and progression of nephropathy in type 2 diabetic patients. Diabetologia 52:698–704. doi:10.1007/s00125-009-1262-6 CrossRef Knudsen ST Laugesen E, Hansen KW, Bek T, Mogensen CE, Poulsen PL (2009) Ambulatory pulse pressure, decreased nocturnal blood pressure reduction and progression of nephropathy in type 2 diabetic patients. Diabetologia 52:698–704. doi:10.​1007/​s00125-009-1262-6 CrossRef
35.
go back to reference Gallego PH, Gilbey AJ, Grant MT et al (2005) Early changes in 24-hour ambulatory blood pressure are associated with high normal albumin excretion rate in children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 18:879–885PubMed Gallego PH, Gilbey AJ, Grant MT et al (2005) Early changes in 24-hour ambulatory blood pressure are associated with high normal albumin excretion rate in children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 18:879–885PubMed
36.
go back to reference Lafferty AR, Werther GA, Clarke CF (2000) Ambulatory blood pressure, microalbuminuria, and autonomic neuropathy in adolescents with type 1 diabetes. Diabetes Care 23:533–538PubMedCrossRef Lafferty AR, Werther GA, Clarke CF (2000) Ambulatory blood pressure, microalbuminuria, and autonomic neuropathy in adolescents with type 1 diabetes. Diabetes Care 23:533–538PubMedCrossRef
37.
go back to reference Poulsen PL, Ebbehoj E, Hansen KW, Mogensen CE (1997) 24-h blood pressure and autonomic function is related to albumin excretion within the normoalbuminuric range in IDDM patients. Diabetologia 40:718–725PubMedCrossRef Poulsen PL, Ebbehoj E, Hansen KW, Mogensen CE (1997) 24-h blood pressure and autonomic function is related to albumin excretion within the normoalbuminuric range in IDDM patients. Diabetologia 40:718–725PubMedCrossRef
38.
go back to reference Hommel E, Mathiesen ER, Giese J, Nielsen MD, Schutten HJ, Parving HH (1989) On the pathogenesis of arterial blood pressure elevation early in the course of diabetic nephropathy. Scand J Clin Lab Invest 49:537–544PubMedCrossRef Hommel E, Mathiesen ER, Giese J, Nielsen MD, Schutten HJ, Parving HH (1989) On the pathogenesis of arterial blood pressure elevation early in the course of diabetic nephropathy. Scand J Clin Lab Invest 49:537–544PubMedCrossRef
39.
go back to reference Karavanaki K, Kazianis G, Kakleas K, Konstantopoulos I, Karayianni C (2007) QT interval prolongation in association with impaired circadian variation of blood pressure and heart rate in adolescents with Type 1 diabetes. Diabet Med 24:1247–1253PubMedCrossRef Karavanaki K, Kazianis G, Kakleas K, Konstantopoulos I, Karayianni C (2007) QT interval prolongation in association with impaired circadian variation of blood pressure and heart rate in adolescents with Type 1 diabetes. Diabet Med 24:1247–1253PubMedCrossRef
40.
go back to reference White WB (2000) Ambulatory blood pressure monitoring: dippers compared with non-dippers. Blood Press Monit 5(Suppl 1):S17–S23PubMedCrossRef White WB (2000) Ambulatory blood pressure monitoring: dippers compared with non-dippers. Blood Press Monit 5(Suppl 1):S17–S23PubMedCrossRef
41.
go back to reference Izzedine H, Launay-Vacher V, Deray G (2006) Abnormal blood pressure circadian rhythm: a target organ damage? Int J Cardiol 107:343–349PubMedCrossRef Izzedine H, Launay-Vacher V, Deray G (2006) Abnormal blood pressure circadian rhythm: a target organ damage? Int J Cardiol 107:343–349PubMedCrossRef
42.
go back to reference Wang X, Poole JC, Treiber FA, Harshfield GA, Hanevold CD, Snieder H (2006) Ethnic and gender differences in ambulatory blood pressure trajectories: results from a 15-year longitudinal study in youth and young adults. Circulation 114:2780–2787PubMedCrossRef Wang X, Poole JC, Treiber FA, Harshfield GA, Hanevold CD, Snieder H (2006) Ethnic and gender differences in ambulatory blood pressure trajectories: results from a 15-year longitudinal study in youth and young adults. Circulation 114:2780–2787PubMedCrossRef
43.
go back to reference Mochizuki Y, Okutani M, Donfeng Y et al (1998) Limited reproducibility of circadian variation in blood pressure dippers and nondippers. Am J Hypertens 11:403–409PubMedCrossRef Mochizuki Y, Okutani M, Donfeng Y et al (1998) Limited reproducibility of circadian variation in blood pressure dippers and nondippers. Am J Hypertens 11:403–409PubMedCrossRef
44.
go back to reference Delaney A, Pellizzari M, Speiser PW, Frank GR (2009) Pitfalls in the measurement of the nocturnal blood pressure dip in adolescents with type 1 diabetes. Diabetes Care 32:165–168PubMedCrossRef Delaney A, Pellizzari M, Speiser PW, Frank GR (2009) Pitfalls in the measurement of the nocturnal blood pressure dip in adolescents with type 1 diabetes. Diabetes Care 32:165–168PubMedCrossRef
45.
go back to reference Cohen CN, Filho FM, de Fatima Goncalves M, de Brito Gomes M (2001) Early alterations of blood pressure in normotensive and normoalbuminuric type 1 diabetic patients. Diabetes Res Clin Pract 53:85–90PubMedCrossRef Cohen CN, Filho FM, de Fatima Goncalves M, de Brito Gomes M (2001) Early alterations of blood pressure in normotensive and normoalbuminuric type 1 diabetic patients. Diabetes Res Clin Pract 53:85–90PubMedCrossRef
Metadata
Title
Ambulatory blood pressure measurements are related to albumin excretion and are predictive for risk of microalbuminuria in young people with type 1 diabetes
Authors
M. L. Marcovecchio
R. N. Dalton
C. P. Schwarze
A. T. Prevost
H. A. W. Neil
C. L. Acerini
T. Barrett
J. D. Cooper
J. Edge
J. Shield
B. Widmer
J. A. Todd
D. B. Dunger
Publication date
01-06-2009
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 6/2009
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-009-1327-6

Other articles of this Issue 6/2009

Diabetologia 6/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.